The presence of a cancer stem cell or tumor “initiating” population is well accepted in the highly malignant brain tumor glioblastoma multiforme (GBM), and is defined as CD133+ cells with neural stem cell-like properties (i.e., capable of forming neurospheres in vitro and neural tumors in in vivo models) [73]. The gene discussed is PROM1; the disease is glioblastoma.